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Native Type I Collagen is Not a Substrate for MMP2
(Gelatinase A)
To the Editor:
A recent JID paper by Herouy et al. (1998) presented some interesting
new data on lipodermatoschlerosis. Their interpretations of the data,
however, are based upon a single paper in the MMP literature (Aimes
and Quigley, 1995), which claims that MMP2 (gelatinase A) is an
interstitial collagenase, a claim that we have not been able to confirm.
We were the first laboratory to purify, characterize, and clone human
MMP2 (Seltzer et al, 1981; Collier et al, 1988). We found that this
proteinase had absolutely no activity against helical collagen. Native
helical collagen is defined by its resistance to trypsin cleavage and
characteristic viscosity in solution. Subsequent work from our labor-
atory has shown that MMP2 is an extremely opportunistic proteinase
against any collagenous sequence in which the helicity is not perfect.
For example, MMP2 cleaves helical type VII collagen within the
helical portion of the molecule, but in an area that has relaxed
helicity (Seltzer et al, 1989). When the Aimes and Quigley paper was
published we confirmed our original observations using pure TIMP-
free MMP2 and helical collagen shown to be trypsin resistant. Inter-
stitial type I collagen in which the helix was relaxed enough to render
it susceptible to trypsin digestion was indeed susceptible to digestion
by MMP2. Intact helical collagen was not. Ohuchi et al (1997) have
recently reconfirmed our original findings.
Cleavage of interstitial collagen by MMP1 yields two characteristic
fragments, which lose their helicity at 37°C and become soluble.
Therefore, solubilization of type I collagen is not indicative of MMP2
activity, but is of MMP1 activity. Herouy et al clearly show active
MMP1 in their western immunoblots, indicating that cleavage of
labeled type I collagen by their extracts can definitely occur.
It is important to point out that TIMP-MMP complexes have
been previously described, but are separated when subjected to SDS-
PAGE electrophoresis (Goldberg et al, 1989; Wilhelm et al, 1989).
The high molecular weight band shown in the immunoblots (Fig 2)
by Herouy et al (1998) either are a new type of complex, or represent
an artifact of antipeptide antibodies.
Jo Louise Seltzer and Arthur Z. Eisen
Division of Dermatology, Washington University School of
Medicine, St. Louis, Missouri
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Reply
Lipodermatosclerosis is characterized by distinct morphologic fea-
tures. Prominent perivascular fibrin cuffs and deposition of hemosid-
erin pigments due to red blood cell extravasation are major
tissue changes occurring in patients with severe chronic venous
insufficiency. Perivascular cuffs are highly organized structures
primarily composed of fibrin, laminin, fibronectin, tenascin and
type I and III collagens (Herrick et al, 1992). Fibrous scar tissue
associated with fragmentation of elastic fibers and loss of papillary
structures at the dermal–epidermal junction are further histologic
findings. The dermal–epidermal junction is built up by an extraord-
inarily complex network of interconnecting proteins such as differ-
ent collagen subtypes and laminin (Burgeson and Christiano, 1997).
To understand the molecular basis of these morphologic alterations
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of lipodermatosclerosis, the expression and activity of matrix
metalloproteinases have been analyzed (Herouy et al, 1998). These
proteases belong to a family of soluble and membrane-bound zinc-
dependent endopeptidases (Shapiro, 1998). In our publication,
elevated expression of matrix metalloproteinase-1 and 22 were
detected in liposclerotic lesions on the gene and protein levels. In
addition, increased proteolytic activity of MMP-2 could be proven
by zymography. Immunohistochemical staining localized matrix
metalloproteinase-2 predominantly in the basal epidermal layer,
around perivascular cuffs and in scar tissue with degraded elastic
fibers. Based on these data we concluded that proteolytic degrada-
tion of major structural proteins by matrix metalloproteinases might
contribute to the pathogenesis and the clinical features found in
patients with chronic venous insufficiency.
In the previous letter to the editor, Seltzer and Eisen stated that
we interpreted the observed proteolytic activity of tissue extracts
on type I collagen as MMP-2 activity. Our conclusion relies on
experimental studies performed by Aimes and Quigley, who claimed
MMP-2 to be an interstitial collagenase (Aimes and Quigley, 1995).
Obviously this consideration is not shared by Selzer and Eisen.
They solely consider helix-relaxed forms and not native helical
type I collagen as substrates for MMP-2 (Seltzer et al, 1981).
According to this view our previously reported data indicate that
lipodermatosclesis is not only characterized by enhanced proteolytic
activity of MMP-2, but also of MMP-1. As suggested by Seltzer
and Eisen, this broader interpretation might help to define more
precisely the complex process in lesional skin of lipodermatoscl-
erosis.
Yared Herouy, Wolfgang Vanscheidt, and Johannes Norgauer
Department of Dermatology, University Hospital, Freiburg,
Germany
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